Barclays Maintains Overweight on Newmont, Lowers Price Target to $124

Benzinga Newsdesk www.benzinga.com Negative 65.3%

Neg 65.3% Neu 0% Pos 0%

Barclays analyst Richard Garchitorena maintains Newmont (NYSE:NEM) with a Overweight and lowers the price target from $125 to $124.